IPO Boutique Research, Color & More Information for Subscribers
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Rigel Pharmaceuticals Symbol: RIGL Price: Last trade $2.08 Description: Re-offer $2.00 Trade Date: 1/31 Shares: 17.5 million Underwriter(s)Jefferies, Piper Jaffray, BMO[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Proteostasis Therapeutics Symbol: PTI Price: Last trade $15.24 Trade Date: 9/9 Shares: 4.25 million Underwriter(s)Leerink Partners, RBC Capital Markets, H.C. Wainwright[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Pacific DataVision, Inc. Symbol: PDVW Price: Last trade $50.00 Trade Date: 5/12 Shares: 1.6 million Underwriter(s) FBR Capital Markets Co Manager(s)[…]